relacorilant

Key facts

INN

relacorilant

Brand

LIFYORLI (COPACKAGED)

Route

ORAL

Formulation

CAPSULE

Originator

CORCEPT THERAPEUTICS INC

Related patents

patent

US 12097192

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11944617

Concomitant administration of glucocorticoid receptor modulator relacorilant and

Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11925626

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused a

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11684612

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort

Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11590113

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort

Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11464764

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused a

Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11285145

Concomitant administration of glucocorticoid receptor modulator relacorilant and

Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11058670

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort

Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is relacorilant?

relacorilant (LIFYORLI (COPACKAGED)), is a pharmaceutical active ingredient, associated with CORCEPT THERAPEUTICS INC, with approved status in the US.

What is the brand name for relacorilant?

LIFYORLI (COPACKAGED) is a marketed brand name for relacorilant. Check FDA Drugs@FDA for the current US label holder.